Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill & Intangibles (2020 - 2025)

Historic Goodwill & Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $315.3 million.

  • Maravai Lifesciences Holdings' Goodwill & Intangibles fell 1561.44% to $315.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.3 million, marking a year-over-year decrease of 1561.44%. This contributed to the annual value of $354.8 million for FY2024, which is 3513.26% down from last year.
  • Maravai Lifesciences Holdings' Goodwill & Intangibles amounted to $315.3 million in Q3 2025, which was down 1561.44% from $322.5 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Goodwill & Intangibles peaked at $568.2 million during Q1 2023, and registered a low of $208.4 million during Q1 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Goodwill & Intangibles value was $500.4 million (recorded in 2022), while the average stood at $428.2 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Goodwill & Intangibles skyrocketed by 8506.53% in 2022, and later tumbled by 6142.14% in 2025.
  • Maravai Lifesciences Holdings' Goodwill & Intangibles (Quarter) stood at $270.4 million in 2021, then soared by 85.07% to $500.4 million in 2022, then rose by 9.32% to $547.0 million in 2023, then tumbled by 35.13% to $354.8 million in 2024, then decreased by 11.14% to $315.3 million in 2025.
  • Its last three reported values are $315.3 million in Q3 2025, $322.5 million for Q2 2025, and $208.4 million during Q1 2025.